强生30年老将，跳槽

医疗器械创新网2025-04-29

近日，全球胰岛素贴片泵领域领军企业Insulet宣布重要人事变动：强生全球医疗技术前负责人Ashley McEvoy正式加盟，出任总裁兼首席执行官，接替自 2022 年起掌舵的Jim Hollingshead。这一调整被视为Insulet加速开拓1型/2型糖尿病市场的关键布局。01强生30年老将接棒McEvoy的履历堪称医疗行业 “资深玩家”：1993 年加入强生，深耕近 30 年，历任 ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2531954279?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-29 14:18","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2531954279","market":"us","top_or_hot":-1,"title":"强生30年老将，跳槽","media":"医疗器械创新网","content":"<div>\n<p>近日，全球胰岛素贴片泵领域领军企业Insulet宣布重要人事变动：强生全球医疗技术前负责人Ashley McEvoy正式加盟，出任总裁兼首席执行官，接替自 2022 年起掌舵的Jim Hollingshead。这一调整被视为Insulet加速开拓1型/2型糖尿病市场的关键布局。01强生30年老将接棒McEvoy的履历堪称医疗行业 “资深玩家”：1993 年加入强生，深耕近 30 年，历任 ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429151328a46b9f03&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>强生30年老将，跳槽</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n强生30年老将，跳槽\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-29 14:18 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429151328a46b9f03&s=b><strong>医疗器械创新网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>近日，全球胰岛素贴片泵领域领军企业Insulet宣布重要人事变动：强生全球医疗技术前负责人Ashley McEvoy正式加盟，出任总裁兼首席执行官，接替自 2022 年起掌舵的Jim Hollingshead。这一调整被视为Insulet加速开拓1型/2型糖尿病市场的关键布局。01强生30年老将接棒McEvoy的履历堪称医疗行业 “资深玩家”：1993 年加入强生，深耕近 30 年，历任 ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429151328a46b9f03&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU1221951129.SGD","symbol_name":"NORDEA 1 STABLE RETURN \"HM\" (SGDHDG) INC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429151328a46b9f03&s=b","article_id":"2531954279","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250429151328a46b9f03&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2531954279","pubTimestamp":1745907539,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"近日，全球胰岛素贴片泵领域领军企业Insulet宣布重要人事变动：强生全球医疗技术前负责人Ashley McEvoy正式加盟，出任总裁兼首席执行官，接替自 2022 年起掌舵的Jim Hollingshead。受领导层变动影响，原定于 6 月初举行的年度投资者日会议将延期举行，新日期有待进一步公布。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU1221951129.SGD":"NORDEA 1 STABLE RETURN \"HM\" (SGDHDG) INC","LU1778281490.HKD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (HKD) INC","LU1244550577.SGD":"FTIF - Franklin Global Multi-Asset Income A (Mdis) SGD-H1","LU1221951046.USD":"NORDEA 1 STABLE RETURN \"HM\" (USDHDG) INC","LU2430703251.USD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4\" (USD) INC","LU0795875169.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD-H","LU0345770308.USD":"NINETY ONE GSF GLOBAL STRATEGIC EQUITY \"A\" (USD) ACC","LU1066051225.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AC\" (USD) ACC","LU0203345920.USD":"SCHRODER ISF QEP GLB ACT. VL \"A\" (USD) ACC","LU1066051498.USD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (USD) INC","BK4534":"瑞士信贷持仓","LU1732799900.SGD":"JPMorgan Investment Funds - Global Income A (irc) SGD-H","LU1196500208.SGD":"NORDEA STABLE RETURN \"HB\" (SGDHDG) ACC","IE00B2B36J28.USD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I1\" (USD) INC","JNJ":"强生","IE00BLSP4239.USD":"Legg Mason ClearBridge - Tactical Dividend Income A Mdis USD Plus","LU2505996681.GBP":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (GBPHDG) INC","LU1674673691.USD":"HSBC GIF GLOBAL LOWER CARBON EQUITY \"AD\" (USD) INC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU0889566641.SGD":"FTSF - Templeton Shariah Global Equity A Acc SGD","IE0002270589.USD":"LEGG MASON CLEARBRIDGE VALUE \"A\" (USD) INC","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","LU2505996509.AUD":"WELLINGTON MULTI-ASSET HIGH INCOME \"AM4H\" (AUDHDG) INC","LU1914381329.SGD":"Allianz Best Styles Global Equity Cl ET Acc H2-SGD","IE00BVYPNV92.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) ACC","SG9999002232.USD":"Allianz Global High Payout USD","LU0985320562.USD":"NORDEA 1 GLOBAL STARS EQUITY \"BP\" (USD) ACC","LU0912757837.SGD":"JPMorgan Investment Funds - Global Income A (mth) SGD-H","LU1506573853.SGD":"MANULIFE GF GLOBAL EQUITY \"AA\" (SGD) INC","LU1267930813.SGD":"FRANKLIN TEMPLETON SHARIAH GLOBAL EQUITY \"AS\" (SGD) ACC","LU1718418525.SGD":"JPMorgan Investment Funds - Global Select Equity A (acc) SGD","IE00B3PB1722.GBP":"GUINNESS GLOBAL EQUITY INCOME \"C\" (GBP) INC","IE00BJJMRZ35.SGD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"I2\" (SGDHDG) ACC","IE00B7SZLL34.SGD":"Legg Mason ClearBridge - Value A Acc SGD-H","LU1066051811.HKD":"HSBC GIF GLOBAL EQUITY VOLATILITY FOCUSED \"AM2\" (HKD) INC","LU1935042991.SGD":"MANULIFE GF GLOBAL MULTI-ASSET DIVERSIFIED INCOME  \"AA\" (SGDHDG) INC","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","LU2133065610.SGD":"JPMorgan Investment Funds - Global Dividend A (mth) SGD","IE00BN8TJ469.HKD":"FTGF CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A\" (HKD) INC","LU0795875086.SGD":"JPMorgan Investment Funds - Global Income A (div) SGD","BK4550":"红杉资本持仓","LU2129689605.HKD":"FRANKLIN GLOBAL INCOME \"A\" (HKD) INC","LU1162221912.USD":"FRANKLIN INCOME \"A\" (USD) ACC","LU0640476718.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQ \"AU\" (USD) ACC","IE00B4R5TH58.HKD":"JANUS HENDERSON GLOBAL LIFE SCIENCES \"A2\" (HKD) ACC","LU2129689514.USD":"FRANKLIN GLOBAL INCOME \"A\" (USD) INC","LU1280957306.USD":"THREADNEEDLE (LUX) US CONTRARIAN CORE EQUITIES \"AUP\" (USD) INC","LU1929549753.HKD":"FRANKLIN INCOME \"A\" (HKD) INC","IE00BBT3K403.USD":"LEGG MASON CLEARBRIDGE TACTICAL DIVIDEND INCOME \"A(USD) ACC","LU0122379950.USD":"贝莱德世界健康科学A2"},"translate_title":"Johnson & Johnson 30-year veteran, job hopping","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"JNJ":1},"content_text":"近日，全球胰岛素贴片泵领域领军企业Insulet宣布重要人事变动：强生全球医疗技术前负责人Ashley McEvoy正式加盟，出任总裁兼首席执行官，接替自 2022 年起掌舵的Jim Hollingshead。这一调整被视为Insulet加速开拓1型/2型糖尿病市场的关键布局。01强生30年老将接棒McEvoy的履历堪称医疗行业 “资深玩家”：1993 年加入强生，深耕近 30 年，历任 Ethicon 部门总裁、视力与糖尿病护理集团董事长等核心高管职位，2018 年起担任强生全球医疗技术董事长，直至 2023 年底卸任；现任宝洁公司董事会成员，兼具医疗技术与消费健康领域的跨界经验。McEvoy说：“胰岛素改变了糖尿病治疗，我很荣幸能加入公司，成为下一任首席执行官。”“Insulet拥有巨大的、尚未开发的增长潜力、才华横溢的团队、无与伦比的药房渠道和制造能力，以及非常忠诚的客户——这些都是显著的差异化因素，也是持续成功的坚实基础。”她说：“在公司和市场发展的关键时刻，胰岛素有一个独特的机会来加强创新，推动全球扩张，并通过对糖尿病患者的体验和需求进行不同的思考来赢得更多供应商和消费者的心。”“我很高兴能与胰岛素的成功团队一起工作，在这个过程中，继续革新糖尿病治疗，让糖尿病患者的生活更轻松，同时为股东创造价值。”Insulet董事长Timothy Scannell表示：“我们的董事会进行了一次彻底的搜索，以确定一位对医疗技术市场有深刻理解、对改善生活有热情、充满活力的高管。在Ashley身上，我们不仅找到了一位拥有近三十年医疗保健领导经验的世界级领导者，而且还找到了一位在医疗技术和消费者健康交叉领域拥有独特见解的远见卓识者。”02前任 CEO 卸任Hollingshead的离职同样引发关注。作为前董事会成员，他 2022 年临危受命，带领Insulet完成关键产品突破：旗下 Omnipod 5 无管胰岛素输送系统 于 2022 年推出，去年，该设备成为美国 FDA 首个批准用于成人 2 型糖尿病患者的自动化胰岛素泵，直接触达 600 万潜在用户（含 250 万每日多次注射患者）；任职期间，Insulet凭借该产品简化糖尿病管理流程，全球用户量突破数十万。“担任Insulet的首席执行官是我的荣幸，”Hollingshead说，他将在过渡期间担任顾问。“我为我们的团队通过Omnipod平台的简单性和复杂性重新定义糖尿病护理所取得的成就感到无比自豪。”他补充说：“我将永远感谢胰岛素的所有同事，他们对改善和简化糖尿病患者生活的热情和奉献精神，这使我们取得了巨大的成功，更重要的是帮助我们在全球范围内吸引了数十万客户。”“我期待着看到未来将实现的所有目标。”该公司计划于 5 月 8 日召开第一季度财报电话会议，并透露预计业绩将超出此前预期，因此上调了本年度剩余时间的财务展望。受领导层变动影响，原定于 6 月初举行的年度投资者日会议将延期举行，新日期有待进一步公布。▲文章来源：医疗器械创新网▲转载请标注以上来源声明：本文仅作信息传递之目的，仅供参考。本文不对投资及治疗构成任何建议，请谨慎甄别。如涉及作品内容、版权和其它问题，为保障双方权益，请与我们联系，我们将立即处理。如有平台转载本篇文章，须自行对该篇文章负责，医疗器械创新网不对转载引起的二次传播负责。往/期/回/顾GE重大人事变动，新总裁“五一”到任！巨头混战！谁能拿下BD2000亿“大蛋糕”？卷哭同行，联影再包揽1.13亿大标！","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2531954279","isCrawlerRequest":true}